AdvanCell

Alpha-9 Theranostics

This clinical-stage biotechnology company develops targeted radiopharmaceuticals to treat cancer patients by delivering radiation directly to tumours while sparing healthy tissue.

Full-Life Technologies

This company develops radiopharmaceuticals and radionuclide drug conjugates to treat cancer patients through targeted alpha therapy.

Actithera

This biotechnology company develops targeted radioligand therapies to treat cancer patients by delivering radioactive isotopes directly to solid tumours.

Actithera Group

This company develops radioligand therapies to treat cancer patients by delivering radiation directly to solid tumours while sparing healthy tissue.

Aktis Oncology

This biotechnology company develops alpha-emitting radiopharmaceuticals to treat patients with solid tumor cancers.

Rocket Isotopes AG

The company produces medical radioisotopes for pharmaceutical firms and clinical trials to facilitate radioligand therapies for cancer patients.

Alpha-9

Alpha-9 Oncology develops targeted radiopharmaceuticals and imaging compounds for the treatment of patients with various types of cancer.

Nuclidium

This clinical-stage company develops copper-based radiopharmaceuticals for the diagnosis and treatment of cancer patients.